Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiroscience Chirocaine

Executive Summary

Company submitted levobupivacaine NDA April 29 for local, regional, epidural and spinal anesthesia in surgical and obstetric procedures, and as an epidural infusion for post-surgical and intractable pain, alone or in combination with morphine, fentanyl or clonidine. Pediatric dosing information is included in the submission. The NDA is the first submitted in U.S. for the Cambridge, U.K. company. Zeneca has rights to market Chirocaine in the U.S and abroad, except for Japan...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS032101

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel